Top Markets
Coin of the day
Australian Clinical Labs Limited Australian Clinical Labs Limited

Australian Clinical Labs Limited

ACL
Rangering i aksjer #15163
Australian Clinical Labs Limited operates across Australia, delivering a... Australian Clinical Labs Limited operates across Australia, delivering a diverse range of diagnostic pathology services. The company's extensive portfolio encompasses standard examinations alongside advanced molecular genetics, including Harmony NIPT and initial trimester screenings, as well as genetic carrier screening. Furthermore, it provides detailed analyses in chemical, tissue (histopathology), and cellular (cytopathology) pathology; specialized tests for hematology, allergies, and immunology; and comprehensive serology and microbiology services. ACL also performs infectious molecular testing, cardiac diagnostic assessments, functional pathology, veterinary pathology, and commercial drug and alcohol screening. These essential services are supplied to both private and public hospitals throughout the nation. The company was founded in 2020 and maintains its primary operational base in Clayton, Australia.
Aksjekurs
$1.98
Markedsverdi
$368.99M
Endring (1 dag)
0.90%
Endring (1 år)
11.38%
Land
AU
Handel Australian Clinical Labs Limited (ACL)

Kategori

P/S-forhold for Australian Clinical Labs Limited (ACL)
P/S-forhold per 2026 TTM: 0
Ifølge Australian Clinical Labs Limited sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Australian Clinical Labs Limited fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
4.95 -
US
5.98 -
US
- -
CN
17.03 -
US
9.64 -
US